Massive brain cancer study aims to map the best path forward after recurrence
NCT ID NCT07448480
Summary
This study aims to understand which treatment sequences work best for patients whose aggressive brain tumors have returned. Researchers will analyze the medical records of about 1,000 patients to see how different chemotherapy and targeted drug combinations affect survival and time until the cancer progresses again. The goal is to create a clearer, evidence-based guide for doctors on the most effective order to give treatments based on a patient's specific tumor type.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOBLASTOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Blokhin's Russian Cancer Research Center
Moscow, 115478, Russia
Conditions
Explore the condition pages connected to this study.